฿
2.77
Apr 18
Business Description
Vibhavadi Medical Center PCL
ISIN : TH0295010R14
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | 3.82 | |||||
Interest Coverage | 4.11 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.07 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.8 | |||||
3-Year EBITDA Growth Rate | 22.1 | |||||
3-Year EPS without NRI Growth Rate | 36.6 | |||||
3-Year Book Growth Rate | 16.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.95 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.42 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 12.38 | |||||
Days Sales Outstanding | 18.46 | |||||
Days Payable | 27.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 6.9 | |||||
Shareholder Yield % | 5.79 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.62 | |||||
Operating Margin % | 15.4 | |||||
Net Margin % | 10.59 | |||||
FCF Margin % | 15.86 | |||||
ROE % | 6.62 | |||||
ROA % | 3.01 | |||||
ROIC % | 3.34 | |||||
ROC (Joel Greenblatt) % | 18.87 | |||||
ROCE % | 7.27 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.44 | |||||
PE Ratio without NRI | 41.96 | |||||
Shiller PE Ratio | 28.84 | |||||
Price-to-Owner-Earnings | 30.14 | |||||
PEG Ratio | 3.2 | |||||
PS Ratio | 3.55 | |||||
PB Ratio | 2.26 | |||||
Price-to-Tangible-Book | 2.41 | |||||
Price-to-Free-Cash-Flow | 22.29 | |||||
Price-to-Operating-Cash-Flow | 15.97 | |||||
EV-to-EBIT | 22.75 | |||||
EV-to-Forward-EBIT | 40.39 | |||||
EV-to-EBITDA | 16.14 | |||||
EV-to-Forward-EBITDA | 27.94 | |||||
EV-to-Revenue | 4.39 | |||||
EV-to-Forward-Revenue | 6.08 | |||||
EV-to-FCF | 27.7 | |||||
Price-to-Projected-FCF | 1.47 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.59 | |||||
Price-to-Graham-Number | 2.12 | |||||
Earnings Yield (Greenblatt) % | 4.4 | |||||
FCF Yield % | 4.47 | |||||
Forward Rate of Return (Yacktman) % | 18.6 |